DHL-11, a novel prieurianin-type limonoid isolated from Munronia henryi, targeting IMPDH2 to inhibit triple-negative breast cancer
Peer-Reviewed Publication
Peer-Reviewed Publication
Latest News Releases
Updates every hour. Last Updated: 29-Jun-2026 14:15 ET (29-Jun-2026 18:15 GMT/UTC)
Peer-Reviewed Publication
Deep learning-based discovery of tetrahydrocarbazoles as broad-spectrum antitumor agents and click-activated strategy for targeted cancer therapy
Peer-Reviewed Publication
Scientists now know why ovarian cancer spreads so rapidly in the abdomen
Peer-Reviewed Publication
Researchers discover ABCA1 protein’s role in releasing molecular brakes on solid tumor immunotherapy
Peer-Reviewed Publication
New artificial intelligence tool may help personalize ovarian cancer treatment from day one
Peer-Reviewed Publication
Americans prefer to screen for cervical cancer in-clinic vs. at home
Peer-Reviewed Publication
Dual-action molecule design concentrates cancer treatment in tumor cells to allow higher doses
Peer-Reviewed Publication
Understanding how cancer cells use water pressure to move through the body
Peer-Reviewed Publication
A new experimental strategy uses gene editing against tumours with too many oncogenes
Peer-Reviewed Publication
Killing cancer cells with RNA therapeutics
Peer-Reviewed Publication